Nisa Investment Advisors, LLC Keros Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $16.7 Billion
- Q3 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 86 shares of KROS stock, worth $5,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86
Previous 62
38.71%
Holding current value
$5,035
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KROS
# of Institutions
174Shares Held
30.3MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$147 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$111 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$109 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$89.2 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$88.7 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.51B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...